Assessment of Atorvastatin Effectiveness on Serum PSA Level in Hypercholesterolemic Males
The previous large retrospective studies demonstrated that treatment with Statins reduces both the incidence of prostate cancer by 50% and serum Prostate Specific Antigen (PSA) level up to 40%. However the main problem in those studies was the absence of control groups of men with hypercholesterolem...
Principais autores: | Iradj Khosropanah, Siavash Falahatkar, Babak Farhat, Zhoobin Heidari Bateni, Ahmad Enshaei, Ali Akbar Allahkhah, Darya Khosropanah |
---|---|
Formato: | Artigo |
Idioma: | English |
Publicado em: |
Tehran University of Medical Sciences
2011-12-01
|
coleção: | Acta Medica Iranica |
Assuntos: | |
Acesso em linha: | https://acta.tums.ac.ir/index.php/acta/article/view/3840 |
Registros relacionados
-
Assessment of Atorvastatin Effectiveness on Serum PSA Level in Hypercholesterolemic Males
por: Darya Khosropanah, et al.
Publicado em: (2011-12-01) -
Antioxidant status of atorvastatin in hypercholesterolemic patients
por: Nasar Mohammad A., et al.
Publicado em: (2009-01-01) -
Zonal adjusted PSA density improves prostate cancer detection rates compared with PSA in Taiwanese males with PSA < 20 ng/ml
por: Tsung-Hsin Chang, et al.
Publicado em: (2020-10-01) -
Relation between Serum Level of Total PSA and Free PSA/Total PSA Ratio with Grade of Prostate Cancer
por: Mohammad Yazdani, et al.
Publicado em: (2013-10-01) -
Is serum PSA a predictor of male hypogonadism? Testing the hypothesis
por: Collins Amadi, et al.
Publicado em: (2021-02-01)